Association between Dipeptidyl Peptidase-4 Inhibitor Prescription and Erythropoiesis-Stimulating Agent Hyporesponsiveness in Hemodialysis Patients with Diabetes Mellitus

• Main Authors: Takeshi Hasegawa (Author), Junhui Zhao (Author), Brian Bieber (Author), Jarcy Zee (Author), Ronald L. Pisoni (Author), Bruce M. Robinson (Author), Norio Hanafusa (Author), Masaomi Nangaku (Author)
• Format: Book
• Published: Karger Publishers, 2021-04-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Introduction: Dipeptidyl peptidase-4 (DPP-4) has been hypothesized to improve responsiveness to erythropoiesis-stimulating agent (ESA). We aimed to describe the trend in DPP-4 inhibitor prescription patterns and assess the association between DPP-4 inhibitor prescription and ESA hyporesponsiveness (...